Potential biomarkers in endometrial cancer: a narrative review

被引：8

作者：

Moar, Kareena ^{[1
]}

Pant, Anuja ^{[1
]}

Saini, Vikas ^{[2
]}

Maurya, Pawan Kumar ^{[1
]}

机构：

[1] Cent Univ Haryana, Dept Biochem, Mahendragarh 123031, India

[2] Cent Univ Haryana, Dept Vocat Studies & Skill Dev, Biomed Sci, Mahendragarh, India

来源：

BIOMARKERS | 2023年 / 28卷 / 04期

关键词：

Endometrial cancer; biomarker; mutation; classification; angiogenic factors; MISMATCH REPAIR-DEFICIENCY; POLYCYSTIC-OVARY-SYNDROME; ORAL-CONTRACEPTIVES; BREAST-CANCER; IMMUNOHISTOCHEMICAL EXPRESSION; RECEPTOR-ALPHA; LYNCH SYNDROME; CARCINOMA; RISK; ESTROGEN;

D O I：

10.1080/1354750X.2023.2179114

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

ContextEvery year, approximately 0.4 million women suffer from endometrial cancer (EC) worldwide and it has become the most common gynecological malignancy. Almost 66% of EC cases are diagnosed at an early stage and can be cured by performing surgery while those at an advanced stage turns out to be fatal. Biomarkers of endometrial cancer would be very valuable for screening of women who are at high risk and in detecting the chance of recurrence of disease.ObjectiveThe current article has reviewed studies published on expression of biomarkers and susceptibility to EC.MethodsGoogle Scholar and PubMed were used as searching platforms and we have majorly considered the literature from last 10 years.ResultsPotential biomarkers of EC identified from various studies were summarised.

引用

页码：358 / 371

页数：14

共 50 条

[31] Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review
Dalil, Davood
Iranzadeh, Saeid
Kohansal, Soroush
FRONTIERS IN PHARMACOLOGY, 2022, 13
[32] Risk-Tailoring Radiotherapy for Endometrial Cancer: A Narrative Review
Hsieh, Kristin
Bloom, Julie R.
Dickstein, Daniel R.
Shah, Anuja
Yu, Catherine
Nehlsen, Anthony D.
Salgado, Lucas Resende
Gupta, Vishal
Chadha, Manjeet
Sindhu, Kunal K.
CANCERS, 2024, 16 (07)
[33] Models including preoperative plasma levels of angiogenic factors, leptin and IL-8 as potential biomarkers of endometrial cancer
Roskar, Luka
Pusic, Maja
Roskar, Irena
Kokol, Marko
Pirs, Bostjan
Smrkolj, Spela
Rizner, Tea Lanisnik
FRONTIERS IN ONCOLOGY, 2022, 12
[34] Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review
Montalvo-Jave, Eduardo E.
Rahnemai-Azar, Amir A.
Papaconstantinou, Dimitrios
Espejel Deloiza, Mariana
Tsilimigras, Diamantis I.
Moris, Dimitrios
Mendoza-Barrera, German Eduardo
Weber, Sharon M.
Pawlik, Timothy M.
SURGICAL ONCOLOGY-OXFORD, 2019, 31 : 83 - 89
[35] Biological markers with potential clinical value in endometrial cancer - review of the literature
Taoussi, Nadia
Alghamdi, Ali
Futyma, Konrad
Rechberger, Tomasz
GINEKOLOGIA POLSKA, 2017, 88 (06) : 331 - 336
[36] Endometrial Cancer After Endometrial Ablation: Systematic Review of Medical Literature
AlHilli, Mariam M.
Hopkins, Matthew R.
Famuyide, Abimbola O.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2011, 18 (03) : 393 - 400
[37] Metabolomics biomarkers and related pathways in endometrial cancer: A systematic review and meta-analysis
Yan, Xingxu
Zhao, Shan
He, Junjie
Sun, Guijiang
Wang, Fang
Ding, Haoran
Zhang, Wenqing
Qian, Wenxiu
Li, Xiaomeng
Wang, Yuyan
Li, Yubo
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (10)
[38] Management of Endometrial Cancer: A Comparative Review of Guidelines
Kopatsaris, Stergios
Tsakiridis, Ioannis
Kapetanios, Georgios
Zachomitros, Fotios
Michos, Georgios
Papanikolaou, Evangelos
Athanasiadis, Apostolos
Dagklis, Themistoklis
Kalogiannidis, Ioannis
CANCERS, 2024, 16 (21)
[39] The Role of Metabolic Syndrome in Endometrial Cancer: A Review
Yang, Xiao
Wang, Jianliu
FRONTIERS IN ONCOLOGY, 2019, 9
[40] Review of Mendelian Randomization Studies on Endometrial Cancer
Guo, Jian-Zeng
Wu, Qi-Jun
Liu, Fang-Hua
Gao, Chang
Gong, Ting-Ting
Li, Gang
FRONTIERS IN ENDOCRINOLOGY, 2022, 13

← 1 2 3 4 5 →